Harbor Capital Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$297K Buy
2023
Q4
$117K Buy
2023
Q3
$105K Buy
2023
Q2
$104K Buy